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BORNA DISEASE VIRUS INFECTION IN CATS
ABCD guidelines on prevention 
and management
Overview: Borna disease virus (BDV) has a broad
host range, affecting primarily horses and sheep, 
but also cattle, ostriches, cats and dogs. 
In cats, BDV may cause a non-suppurative
meningoencephalomyelitis (‘staggering disease’).
Infection: The mode of transmission is not
completely elucidated. Direct and indirect virus
transmission is postulated, but BDV is not readily
transmitted between cats. Vectors such as ticks
may play a role and shrews have been identified as
a potential reservoir host. Access to forested areas
has been reported to be an important risk factor for
staggering disease. 
Disease signs: It is postulated that BDV may
infect nerve endings in the oropharynx and spread
via olfactory nerve cells to the central nervous
sytem. A strong T-cell response may contribute to
the development of clinical disease. Affected cats
develop gait disturbances, ataxia, pain in the lower
back and behavioural changes.
Diagnosis: For diagnostic purposes, detection of
viral RNA by reverse transcription PCR in samples
collected from cats with clinical signs of Borna
disease can be considered diagnostic. Serology is
of little value; cats without signs of Borna disease
may be seropositive and yet not every cat with 
BDV infection has detectable levels of antibodies.
Human infection: A hypothesis that BDV infection
may be involved in the development of selected
neurological disorders in man could not be
confirmed. A research group within the German
Robert Koch Institute studied the potential health
threat of BDV to humans and concluded that 
BDV was not involved in the aetiology of human
psychiatric diseases.
Background
Borna disease virus (BDV) historically has affected horses and sheep (for
a review see Ludwig and Bode1). The disease was first described in 1855
in horses which became severely sick, near the German town of Borna
(cited in Lundgren et al2). More recently, BDV has been described as the
causative agent of a viral meningoencephalitis in cattle, ostriches, cats
and dogs.1 In the mid-1970s, staggering disease – a non-suppurative
meningoencephalomyelitis – was described in Swedish cats (cited in
Lundgren et al2 and Cubitt and de la Torre3). Later, it was found that anti-
bodies recognising BDV were common to these cases.4 Finally, in 1995,
BDV was confirmed as the aetiological agent of staggering disease.2
Aetiological agent
BDV is an enveloped virus with a helical capsid and a single-stranded
RNA genome. The genome comprises 8900 bases and, based on
sequence analysis, it was assigned to the order of Mononegavirales as
the only member of the Bornaviridae family.3,5 BDV particles are spher-
ical and have an average diameter of approximately 100 nm. The
genome encodes six known proteins including an envelope protein of
56 kd. Interestingly, BDV can infect a number of brain-derived cell
types, but it does not usually induce any cytopathic effect.
Epidemiology
The mode of transmission of BDV has not been completely elucidated. It
is postulated that transmission occurs through direct contact with an
infected animal or indirectly by contact with secretions of an infected
animal. In addition, the local occurrence of disease in forested areas in
Sweden suggests that vectors such as ticks may play a role in transmis-
sion. In 2006, a shrew (Crocidura leucodon) was identified as the reservoir
host in an area of Switzerland where BDV is prevalent in horses and
sheep.6 Shrews could also serve as reservoirs for BDV infection in cats.
BDV infection appears not to be readily transmitted between cats. 
Feline BDV infection has been reported in many countries, including
Germany, Switzerland, Belgium, the United Kingdom, Japan, the
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Philippines, Indonesia, Australia and Finland
(cited in Ludwig and Bode1 and Someya et
al7). The fact that BDV was also shown to be
present in horses in North America and sever-
al other species in Western China suggests
that cats in the USA and China might also be
affected by BDV. Clinical staggering disease
has been mainly observed in Sweden, Austria,
Germany, Switzerland and Liechtenstein.
The seroprevalence in cats with neurologi-
cal disease in different countries has been
reported to vary widely, between 0 and 67%.
In healthy cats, the occurrence of BDV anti-
bodies is much lower, varying between 2%
and over 40%.8 Access to forested areas was
reported to be an important risk factor for
staggering disease, since 68% of all clinical
cases occurred in cats with access to forests.4
Staggering disease shows a clear peak in 
frequency in the spring.9 So far, an association
between BDV infection and gender has not
been described. The findings on the age 
distribution of BDV infection are controver-
sial. A recent study in Japan found no age pre-
dispostion in BDV infection, although cats
younger than 1 year were already found to be
affected.7
Pathogenesis and clinical signs
It is postulated that BDV may infect nerve
endings in the oropharynx, nose and/or intes-
tinal tract. The virus is thought to migrate
along the nerves to the central nervous system
(CNS),10 where it leads to lymphocytic inflam-
mation and neuronal degeneration. A strong
T-cell response to the virus is believed to be
responsible for the development of clinical
signs but other factors may also be important
for disease development.10 Affected cats
develop gait disturbances, ataxia, pain in the
lower back and behavioural changes. In some
cases, cats lose the capacity to retract their
claws. Clinical signs will usually progress and
cats will eventually die after developing
severe paralysis of the hind legs. However,
some cats will recover partially or even 
completely. Subclinical infections can also
occur. 
Immune response
CD8+ lymphocytes stimulated by BDV have
been found in peripheral blood, spleen and
brain.11 These findings suggest that a success-
ful immune reaction usually allows infected
cats to control the infection. A weak innate
immune response to BDV infection was
recently described in rat brain cell cultures.12
It is, therefore, expected that a weak innate
immune response may likewise contribute to
disease development in cats. 
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Diagnosis
Diagnosis on the basis of clinical signs alone 
is not possible as there are several other viral
infections (feline immunodeficiency virus,
feline leukaemia virus and feline coronavirus)
that can lead to similar clinical signs.
Detection of antibodies to BDV by ELISA or
indirect immunofluorescence in cats exhibit-
ing clinical signs typical of BDV infection 
permits a tentative diagnosis.13
However, the diagnostic sensitivity of the
detection of antibodies, at 81%, means that not
every cat with BDV infection will have
detectable levels of antibodies.13 The reason
for this is unclear. It is speculated that differ-
ent strains of BDV exist which are sufficiently
different from the antigen used in the assay
and therefore remain undetected. Alter -
natively, some cats may not be capable of
mounting an immune response that is sero-
logically detectable.
The diagnostic specificity of antibody detec-
tion is also very low, as many seropositive cats
may be completely healthy.13 In the absence of
clinical signs of Borna disease, diagnostic
serology is of little value.
Detection of viral RNA by reverse transcrip-
tion PCR in pooled samples of blood, serum,
urine, conjunctival, nasal, oral and anal swabs
collected from cats with clinical signs of Borna
disease can be considered diagnostic.13
Currently, the most reliable means of diag-
nosis of Borna disease is considered to be
pathology and histopathology.
Pathology
In cats with end-stage staggering disease,
mild neutropenia is observed in about a third
of the affected population. No other changes
in clinical or biochemical parameters are
observed. The most important histopathologi-
cal findings include perivascular cuffing in
the hippocampus, basal ganglia, cerebellum,
cerebrum and grey matter of the brainstem.9
In addition, plasma cells have been frequently
seen in the close vicinity of neurons,14 indica-
tive of an inflammatory reaction and thereby
explaining the clinical findings in cats with
staggering disease. 
Prevention
Currently, no vaccine is available for the 
prevention of staggering disease. As the exact
modes of transmission are still not completely
clear, it is difficult to make specific recommen-
dations for preventive measures. Cats without
access to a rural environment are probably at
lower risk of BDV infection compared with
those with unlimited access to such areas. In
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Board on Cat Diseases
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vaccinology and clinical
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and management of feline
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areas where staggering disease is known to
occur, it might therefore be recommended that
cats should be kept indoors. However, limit-
ing outdoor access should be carefully
weighed against the risk of BDV infection. 
For many cats, outdoor access is an important
component of their wellbeing. 
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Zoono t i c  a spec t s
As BDV persistently infects the CNS of many animal species, it
was postulated that this virus might also infect humans. Indeed,
it was shown that humans can be seropositive for BDV and that
the frequency of BDV antibodies was increased in human
patients with chronic neurological disorders. Specifically, among
70 psychiatric patients, 20% were found to be seropositive,
compared with a few percent of the normal population. This led
to the hypothesis that BDV infection may be involved in the
development of selected neurological disorders,15,16 and trig-
gered the creation of a research group within the German Robert
Koch Institute in the 1990s to study the potential health threat of
BDV to humans. 
In 2007, this research group published a statement that (1) the
methods providing seropositive results in human blood were not
adequate to substantiate the presence of antibodies to BDV; 
and (2) the RNA sequences found in human blood and tissue
were the consequence of BDV contamination in the laboratory of
the respective research laboratory. Therefore, it was concluded
that BDV was not involved in the aetiology of human psychiatric
diseases and after dozens of careful studies the research group
ended its activity. 
For details see http://www.rki.de/DE/Content/Forsch/
Forschungsschwerpunkte/NeueRisiken/NeuartigeErreger/
Einstellung_Projekt_Bornavirus.html.
< Borna disease virus (BDV) is the aetiological agent of staggering
disease, seen in several animal species, including horses, sheep
and cats.
< Transmission probably occurs through direct contact or indirectly
via the secretions of an infected animal.
< Ticks may play a role in transmission.
< Infection starts in the olfactory nerve cells and then spreads to
the central nervous system.
< Signs include an abnormal gait, ataxia progressing to paralysis,
lower back pain and behavioural changes.
< Serological tests are of little diagnostic value.
< Detection of viral RNA by reverse transcription PCR in pooled
samples of body secretions is diagnostic.
< Pathology and histopathology are considered the most 
reliable diagnostic methods.
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